BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thakkar N, Jaishankar D, Agelidis A, Yadavalli T, Mangano K, Patel S, Tekin SZ, Shukla D. Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells. Sci Rep 2017;7:42559. [PMID: 28198435 DOI: 10.1038/srep42559] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lappin M, Wotman K, Chow L, Williams M, Hawley J, Dow S. Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model. PLoS One 2023;18:e0279462. [PMID: 36607992 DOI: 10.1371/journal.pone.0279462] [Reference Citation Analysis]
2 Koganti R, Memon A, Shukla D. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis. Semin Thromb Hemost 2021;47:283-94. [PMID: 33851373 DOI: 10.1055/s-0041-1725068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Yadavalli T, Koganti R, Shukla D. Infection-Induced Porcine Ex Vivo Corneal Wound Model to Study the Efficacy of Herpes Simplex Virus-1 Entry and Replication Inhibitors. Methods Mol Biol 2021;2193:183-96. [PMID: 32808270 DOI: 10.1007/978-1-0716-0845-6_18] [Reference Citation Analysis]
4 O'Neil TR, Hu K, Truong NR, Arshad S, Shacklett BL, Cunningham AL, Nasr N. The Role of Tissue Resident Memory CD4 T Cells in Herpes Simplex Viral and HIV Infection. Viruses 2021;13:359. [PMID: 33668777 DOI: 10.3390/v13030359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yadavalli T, Suryawanshi R, Koganti R, Hopkins J, Ames J, Koujah L, Iqbal A, Madavaraju K, Agelidis A, Shukla D. Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing. Sci Adv 2020;6:eabd9443. [PMID: 33277262 DOI: 10.1126/sciadv.abd9443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Courrier E, Maurin C, Lambert V, Renault D, Bourlet T, Pillet S, Verhoeven PO, Forest F, Perrache C, He Z, Garcin T, Rousseau A, Labetoulle M, Gain P, Thuret G. Ex vivo model of herpes simplex virus type I dendritic and geographic keratitis using a corneal active storage machine. PLoS One 2020;15:e0236183. [PMID: 32697805 DOI: 10.1371/journal.pone.0236183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D. An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Sci Transl Med 2018;10:eaan5861. [PMID: 29444978 DOI: 10.1126/scitranslmed.aan5861] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
8 Lobo AM, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf 2019;17:40-9. [PMID: 30317007 DOI: 10.1016/j.jtos.2018.10.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
9 Agelidis AM, Hadigal SR, Jaishankar D, Shukla D. Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1. Cell Rep 2017;20:439-50. [PMID: 28700944 DOI: 10.1016/j.celrep.2017.06.041] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
10 Pennington MR, Ledbetter EC, Van de Walle GR. New Paradigms for the Study of Ocular Alphaherpesvirus Infections: Insights into the Use of Non-Traditional Host Model Systems. Viruses 2017;9:E349. [PMID: 29156583 DOI: 10.3390/v9110349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
11 Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D. Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection. Mol Ther Nucleic Acids 2017;9:365-78. [PMID: 29246315 DOI: 10.1016/j.omtn.2017.10.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
12 Thakkar N, Yadavalli T, Jaishankar D, Shukla D. Emerging Roles of Heparanase in Viral Pathogenesis. Pathogens 2017;6:E43. [PMID: 28927006 DOI: 10.3390/pathogens6030043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]